Glad to share the outcomes of a recent manuscript, published on Graefe’s Archive for Clinical & Experimental Ophthalmology, assessing the performance of several clinically available riboflavin ophthalmic formulations for corneal cross-linking. The ...
Regensight granted by Lazio Innova for the development of the theranostics platform for the correction of visual disorders
The project n. A0613-2023-077528 of Regensight srl was granted by Lazio Innova in response to the "RSI Competitive Repositioning" Public Notice, FESR Program 2021-2027 referred to in Det. n. G18823 dated 12/28/2022 and granted with the Det. n. G15206 date ...
Great interest in Regensight at the ESCRS 2023
The Regensight team has been an active part of The European Society of Cataract and Refractive Surgery (ESCRS) International Conference, which was held in Vienna from 8 to 11 September 2023.At the startup's stand, the Team has allowed the eye surgeons to ...
Pre-clinical validation outcomes of theranostic-guided corneal cross-linking published
In a recent study published in the prestigious Journal of Cataract & Refractive Surgery, theranostic-guided corneal cross-linking has been confirmed to induce precise and predictive corneal tissue strengthening in eye-bank human donor tissues through ...
Regensight appoints Loredana Alletto as Chief Operating Officer
Loredana Alletto is the Chief Operating Officer of Regensight. She will lead the strategies and operations of Regensight, consistently with the objective of affirming the new paradigm of theranostics for predictive and precision treatment of keratoconu ...
REGENSIGHT AT ESCRS 2023
REGENSIGHT AT ESCRS 2023 Hall C, Booth C405 8 – 11 September Messe Wien, Vienna, Austria Welcome to Vienna to meet REGENSIGHT We are very glad to exhibiting for the first time ever at ESCRS 2023!We at Regensight are introducing th ...
Regensight guest of TeamViewer at Embedded World
Elevating the standard of care to patients starts from the beginning of project development and the real understanding of eye doctors needs. We at Regensight are meeting this challenge and transforming eye doctors experience in treating keratoconus using ...
ARGO clinical trial protocol
The ARGO clinical trial protocol has been published in the “New Treatments for Keratoconus” Special Issue of International Ophthalmology. The publication is open access and available at https://link.springer.com/article/10.1007/s10792-022-02628-4. T ...
Scientific publication on theranostic-guided corneal cross-linking on the cover of Journal of Biophotonics
Pleased to end this amazing year with the honor to see our most recent publication on theranostics on the cover of Journal of Biophotonics. The article is open access and available at https://onlinelibrary.wiley.com/doi/10.1002/jbio.202200218. Theranost ...
The Mario Lombardo Research Prize has been awarded to a young ophthalmologist
The Mario Lombardo award has been assigned to Dr. Raffaella Gioia, a young ophthalmologist recently specialized at the Magna Graecia University of Catanzaro. The celebration was held at the Regensight Research & Development Lab. in Reggio C ...